" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
[11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction
A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data
A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study
A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)
Changes in the T-wave Alternans in Patients With Heart Failure Treated Wih Sacubitril-Valsartan
Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure
Comparing ARNI With ACE Inhibitor on Endothelial Function
Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.
Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting